NEONCOBREAST
Grupo de Investigación en Cáncer de Mama
Publikationen (160) Publikationen, an denen Forscher/innen teilgenommen haben
2024
-
Corrigendum to “European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO” [Eur J Surg Oncol 50 (1) (January 2024) 107292] (European Journal of Surgical Oncology (2024) 50(1), (S0748798323009307), (10.1016/j.ejso.2023.107292))
European Journal of Surgical Oncology
-
Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer
Seminars in Oncology Nursing, Vol. 40, Núm. 1
-
Dendritic Cells in Cancer Immunology and Immunotherapy
Cancers, Vol. 16, Núm. 5
-
EUSOMA quality indicators for non-metastatic breast cancer: An update
European Journal of Cancer, Vol. 198
-
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO
European Journal of Surgical Oncology, Vol. 50, Núm. 1
-
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
European Journal of Nuclear Medicine and Molecular Imaging
-
Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines
European Journal of Nuclear Medicine and Molecular Imaging
-
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature
Journal of Clinical Oncology, Vol. 42, Núm. 10, pp. 1124-1134
-
Long-term results of intraoperative multicatheter breast implant (IOMBI) for accelerated partial breast irradiation (APBI) on early breast cancer patients
Radiotherapy and Oncology, Vol. 194
-
Post- versus intra-operative implant for breast cancer interstitial brachytherapy: How to choose?
Journal of Contemporary Brachytherapy, Vol. 16, Núm. 1, pp. 72-83
-
Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line
Clinical and Translational Oncology
-
Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network
European Journal of Cancer, Vol. 196
-
Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort
Radiotherapy and Oncology, Vol. 194
2023
-
Axillary staging and management of cN + breast cancer patients treated with neoadjuvant chemotherapy: results of a survey among breast cancer surgeons in Spain
Clinical and Translational Oncology, Vol. 25, Núm. 5, pp. 1463-1471
-
Delays to surgery following chemoradiotherapy lead to poorer oncologic outcomes in patients with localized pancreatic adenocarcinoma
Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 8, pp. 428-434
-
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy
European Journal of Cancer, Vol. 181, pp. 79-91
-
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
The Lancet Oncology, Vol. 24, Núm. 1, pp. e11-e56
-
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care
European Journal of Cancer, Vol. 187, pp. 105-113
-
Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis
The British journal of surgery, Vol. 110, Núm. 4, pp. 410-419
-
Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment
European Journal of Surgical Oncology, Vol. 49, Núm. 10